Jonathan Koff

Associate Professor

Yale University

United States

Research Interests

Explore related searches

Professors in United States Professors in Microbiology Microbiology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jonathan Koff is an Associate Professor at Yale University in the United States. His research focuses on phage therapy, particularly for respiratory infections and multidrug-resistant infections in cystic fibrosis. He has contributed significantly to the study of COVID-19 and its related complications, exploring innovative treatment options and disease mechanisms through human iPSC-based models.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

Northwestern University Feinberg School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jonathan Koff

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Phage Therapy for Respiratory Infections: Opportunities and Challenges

Human iPSC-Based Model of COPD to Investigate Disease Mechanisms, Predict SARS-COV-2 Outcome, and Test Preventive Immunotherapy

Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis

Novel subtypes of severe COVID-19 respiratory failure based on biological heterogeneity: a secondary analysis of a randomized controlled trial

Optimized preparation pipeline for emergency phage therapy against Pseudomonas aeruginosa at Yale University

Report of the first seven agents in the I-SPY COVID trial: a phase 2, open label, adaptive platform randomised controlled trial

A Novel Zinc (II) Porphyrin Is Synergistic with PEV2 Bacteriophage against Pseudomonas aeruginosa Infections

Bacteriophage Therapy for Pan-Drug-Resistant Pseudomonas aeruginosa in Two Persons With Cystic Fibrosis

COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation

IFN-γ Is Protective in Cytokine Release Syndrome-associated Extrapulmonary Acute Lung Injury

Collaborators (6)

Sheetal Gandotra

Carlos J. Orihuela

ellen burnham

Philip Yang

Lokesh Sharma

Benjamin Singer

Make your next move.